Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing-Remitting Multiple Sclerosis”

713 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 713 results

Not applicableStudy completedNCT05029206
What this trial is testing

Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Uppsala University 174
Not applicableStudy completedNCT05366036
What this trial is testing

Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
Eisai Korea Inc. 172
Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Post-approval studies (Phase 4)Study completedNCT01498887
What this trial is testing

Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 347
Large-scale testing (Phase 3)Looking for participantsNCT05834855
What this trial is testing

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingDemyelinating Autoimmune Diseases, CNS+3 more
Amsterdam UMC, location VUmc 200
Post-approval studies (Phase 4)Ended earlyNCT00203047
What this trial is testing

Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 414
Not applicableStudy completedNCT03942952
What this trial is testing

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more
University of Texas Southwestern Medical Center 49
Not applicableStudy completedNCT01925690
What this trial is testing

Development of a Motivational Intervention to Improve Treatment Adherence in MS

Who this might be right for
Relapsing-remitting Multiple Sclerosis
University of Missouri, Kansas City 80
Not applicableStudy completedNCT01518660
What this trial is testing

Multiple Sclerosis and Progressive Resistance Training

Who this might be right for
Multiple Sclerosis (Relapsing Remitting)
University of Aarhus 35
Not applicableUnknownNCT05705986
What this trial is testing

Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)

Who this might be right for
Relapse Remitting Multiple Sclerosis
Thomas Jefferson University 40
Testing effectiveness (Phase 2)Ended earlyNCT02222948
What this trial is testing

Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Genzyme, a Sanofi Company 112
Not applicableStudy completedNCT01112345
What this trial is testing

An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 133
Testing effectiveness (Phase 2)Active Not RecruitingNCT06800404
What this trial is testing

"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Multiple Sclerosis
Hope Biosciences Research Foundation 10
Not applicableLooking for participantsNCT06567197
What this trial is testing

Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Amsterdam UMC, location VUmc 24
Not applicableUnknownNCT04993274
What this trial is testing

Sensitivity of Motor Assessment in MS - a Prospective Cohort Study

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Chronic Progressive
Friedemann Paul 100
Not applicableStudy completedNCT00818038
What this trial is testing

A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 30
Not applicableActive Not RecruitingNCT06095271
What this trial is testing

MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University Hospital, Basel, Switzerland 920
Early research (Phase 1)Active Not RecruitingNCT06430671
What this trial is testing

Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Cellerys AG 11
Not applicableStudy completedNCT06526000
What this trial is testing

Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated SyndromeRelapsing-remitting Multiple Sclerosis+1 more
Novartis 326
Not applicableStudy completedNCT00493298
What this trial is testing

Tysabri Observational Program

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 6,620
Load More Results